Hopp til hovedinnhold


Sist revidert:
Sist revidert av:

  1. Hill DA, Taylor CA. Dyspareunia in Women. Am Fam Physician. 2021;103(10):597-604. PubMed  
  2. Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7(4 pt 2):1598–1607.
  3. MacNeill C. Dyspareunia. Obstet Gynecol Clin N Am. 2006;33:565-577. PubMed  
  4. De Graaff AA, Van Lankveld J, Smits LJ, et al. Dyspareunia and depressive symptoms are associated with impaired sexual functioning in women with endometriosis, whereas sexual functioning in their male partners is not affected. Hum Reprod. 2016;31(11):2577–2586.
  5. Danielsson I, Sjoberg I, Stenlund H, et al. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health. 2003;31:113-118. PubMed  
  6. Landry T, Bergeron S. How young does vulvo-vaginal pain begin? Prevalence and characteristics of dyspareunia in adolescents. J Sex Med. 2009;6(4):927–935. PMID: 19207275. PubMed  
  7. Stewart EG. Differential diagnosis of sexual pain in women. UpToDate, sist oppdatert oktober 2013
  8. Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–711. PMID: 27472999 PubMed  
  9. Basson R, Wierman ME, van Lankveld J, Brotto L. Summary of the recommendations on sexual dysfunctions in women. J Sex Med. 2010;7 (1 pt 2):314–326.
  10. Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012; 87(2):187–193.
  11. Nunns D, Mandal D, Byrne M, et al. British Society for the Study of Vulval Disease (BSSVD) Guideline Group. Guidelines for the management of vulvodynia published correction appears in Br J Dermatol. 2010;162(6):1416. Br J Dermatol. 2010;162(6):1180–1185.
  12. Leeman LM, Rogers RG. Sex after childbirth: postpartum sexual function. Obstet Gynecol. 2012;119(3):647–655.
  13. Steege JF, Zolnoun DA. Evaluation and treatment of dyspareunia. Obstet Gynecol 2009; 113 (5): 1124. pmid:19384129 PubMed  
  14. Bernstein JA. Human seminal plasma hypersensitivity: an under-recognized women's health issue. Postgrad med 2011; 123 (1): 120-5. doi:10.3810/pgm.2011.01.2253 DOI  
  15. Voorham-van der Zalm PJ, Lycklama A Nijeholt GA, Elzevier HW, et al. "Diagnostic investigation of the pelvic floor": a helpful tool in the approach in patients with complaints of micturition, defecation, and/or sexual dysfunction. J Sex Med 2008; 5 (4): 864-71. pmid:18221287 PubMed  
  16. Buhling KJ. Assessment of dyspareunia. BestPractice, last updated Nov 2017. bestpractice.bmj.com  
  17. Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85(1):87–94.
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Maria Engman, med dr och överläkare, Kvinnokliniken, Västerviks sjukhus (Medibas)